Eclipse MedCorp buys autologous point-of-care technology in regenerative medicine
Medical device company Eclipse MedCorp has acquired worldwide control of an autologous point-of-care technology in regenerative medicine.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Oct 18
Medical device company Eclipse MedCorp has acquired worldwide control of an autologous point-of-care technology in regenerative medicine.
16 Oct 18
Connected health company ResMed has announced the availability of its first minimal-contact full face CPAP mask, AirFit F30,…
15 Oct 18
Palette Life Sciences and Nestlé Skin Health have signed a global licensing agreement for commercialization and development rights…
15 Oct 18
Zingbox and First Health Advisory Solutions have collaborated to deliver a comprehensive security and operations solution for connected…
15 Oct 18
Bardy Diagnostics has secured an innovative technology contract from Vizient for the carnation ambulatory monitor (CAM), which is…
12 Oct 18
Medical therapy company Pulse Biosciences has started a clinical feasibility study using its Nano-Pulse Stimulation (NPS) platform to…
12 Oct 18
Healthcare company Otsuka Pharmaceutical and digital medicinesfirm Proteus Digital Health have expanded their collaboration agreement to advance digital…
12 Oct 18
Medical devices maker TransEnterix has secured 510(k) from the US Food and Drug Administration (FDA) for its 3mm…
10 Oct 18
3M has released advanced surgical skin prep solution aiding in patient infection prevention.
09 Oct 18
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has advised people using Roche’s CoaguChek device to check…